NIH-funded research Fellowship grant

Understanding how brain receptors are delivered to synapses

Official title: Investigating the synaptic trafficking of endogenous AMPARs

Funded at University of Colorado Denver · NIH-10995322 · Data updated 2026-11-12

This study is looking at how certain brain receptors that help with learning and memory get to the right spots in the brain, which could help us understand and find new treatments for conditions like autism and epilepsy.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startDecember 27, 2022
Project endNovember 26, 2025
Funding year2025
Award (this year)$36,082
NIH project number5F31NS130979-03
Project IDNIH-10995322 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with autism spectrum disorder or related brain disorders.

Less likely to help

Patients with conditions unrelated to synaptic dysfunction or those without a diagnosis of autism or similar disorders may not benefit from this research.

What this research studies

This research investigates the mechanisms behind the delivery of AMPA-type glutamate receptors (AMPARs) to synapses in the brain, which are crucial for learning and memory. By developing a new toolkit to label and control the trafficking of these receptors, the research aims to uncover how they are transported to specific synapses under normal conditions and during synaptic changes. This could provide insights into the synaptic dysfunctions observed in conditions like autism and epilepsy, potentially leading to new therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for brain disorders associated with synaptic dysfunction, such as autism and epilepsy.

How similar studies have gone: Other research has shown promising results in understanding synaptic mechanisms, but this approach using endogenous AMPARs is relatively novel.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Kareemo, Dean — University of Colorado Denver
  • Study coordinator: Kareemo, Dean

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.